Overall Survival in Cancer Drug Trials as a New Surrogate End Point for Overall Survival in the Real World
- PMID: 27892992
- DOI: 10.1001/jamaoncol.2016.5296
Overall Survival in Cancer Drug Trials as a New Surrogate End Point for Overall Survival in the Real World
Comment in
-
Overall Survival vs Disease-Specific Survival.JAMA Oncol. 2018 Apr 1;4(4):586. doi: 10.1001/jamaoncol.2016.6786. JAMA Oncol. 2018. PMID: 29167882 No abstract available.
-
Overall Survival vs Disease-Specific Survival-Reply.JAMA Oncol. 2018 Apr 1;4(4):586-587. doi: 10.1001/jamaoncol.2017.3865. JAMA Oncol. 2018. PMID: 29167883 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources